drugset / Trial / NCT00627016
A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-03
- Completion
- 2009-03
Outcome
Met primary endpoint
paper Dexlansoprazole MR 30 mg (n=152) was superior to placebo (n=153) in median percentage of nights without heartburn (73.1 vs. 35.7%, respectively; P<0.001). PMID 21224838 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 30 mg | Oral |